Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease polymyositis
Symptom C0024115|lung disease
Sentences 11
PubMedID- 21950266 Kl-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis.
PubMedID- 24800252 Hyperferritinemia is frequently accompanied by rapidly progressive (rp) interstitial lung disease (ild) with polymyositis (pm)/dermatomyositis (dm).
PubMedID- 21285059 polymyositis associated with severe interstitial lung disease: remission after three doses of iv immunoglobulin.
PubMedID- 23158422 Surfactant proteins-a and d as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis.
PubMedID- 25827843 Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
PubMedID- 25297551 Interstitial lung disease (ild) in patients with polymyositis (pm) and dermatomyositis (dm) is often resistant to treatment and life threatening, being recognized as one of the severest complication in these autoimmune disorders.
PubMedID- 26101728 Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.
PubMedID- 20367973 Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
PubMedID- 23423441 This diagnosis should always come to mind in patients that present with signs of myositis, dermatomyositis, or polymyositis associated with interstitial lung disease.
PubMedID- 24142786 Interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases.
PubMedID- 22325787 Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease.

Page: 1